-
Biomarkers and cell phenotypes in TB patients with minimal or persisting lung inflammation post-anti-TB treatment and ex-vivo atorvastatin immunomodulatory effects on M. tuberculosis-infected PBMC
-
A description of patients with recurrence of pulmonary tuberculosis in TB hospital, Ermelo
-
The involvement of disrupted mitochondrial pathways in pulmonary arterial hypertension as a tuberculosis sequela in a South African cohort.
-
An investigation into the lung function, health-related quality-of-life and functional capacity of a cured pulmonary tuberculosis population in the Breede Valley, South Africa : a pilot study
-
A descriptive study of IgG subclasses and allotypes in children with pulmonary tuberculosis in the Western Cape
-
The Effect of initiating corticosteroids on lung function and symptoms in patients with active pulmonary sarcoidosis
-
The modulating properties of mycobacterial mycolic acids on murine macrophage function
-
Evaluation of host biomarkers for early diagnosis of tuberculosis disease in children
-
Predicting pulmonary hypertension and outcomes in patients with left heart disease
-
The microbiome and inferred function in pulmonary and extrapulmonary tuberculosis.
-
Drug repurposing and optimisation to improve tuberculosis treatment
-
Innovative strategies to improve the diagnosis of intrathoracic tuberculosis in children
-
Accuracy and impact of the MTBDRplus v2 and MTBDRsl v2 line probe assays for the detection of first-line and second-line drug resistant tuberculosis
-
The lung microbiome of Human Immunodeficiency Virus-infected patients with active pulmonary Mycobacterium tuberculosis infection
-
Determination of the pathogenetic mechanisms for, and the diagnostic implications of, raised adenosine deaminase (ADA) levels in tuberculous exudates
-
The establishment, optimisation, and transplantation of a three-dimensional bioprinted syngeneic granuloma model into C57BL/6 mice.
-
Pulmonary tuberculosis in the elderly : diagnostic criteria and its epidemiology in old age homes
-
Diagnostic, prognostic and therapeutic considerations in primary pulmonary hypertension
-
Immunoactive, Antibacterial and Drug-Carrying properties of selective surfactants
-
Investigating the role of respiratory co-infections and the nasopharyngeal microbiome in children with suspected pulmonary tuberculosis
-
Bronchoscopic assessment and management of children presenting with clinically significant airway obstruction due to tuberculosis
-
Validation of the MEP pathway’s [Fe-S] cluster enzymes as drug targets in mycobacteria
-
Assessment, diagnosis and management of pulmonary tuberculosis in children under five years of age in the Langeberg sub-district, Western Cape, South Africa
-
Pro–apoptotic iron oxide nanosystems as selective anti – TB drugs
